Shorter antibiotic course for mild leptospirosis
Part of Infections clinical trials.
This study compares a 3-day course of antibiotics to the standard 7-day course for mild leptospirosis. The goal is to see if a shorter treatment is just as effective, which could mean fewer side effects and lower costs for patients.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You are being treated at one of the participating hospitals in Martinique, Guadeloupe, French Guiana, Reunion, or Mayotte.
- You have a confirmed leptospirosis diagnosis (via a blood test or PCR) within 3 days of starting antibiotics.
- You are covered by health insurance (or state medical aid in French Guiana).
- You agree to participate and return for follow-up visits at 7 and 21 days after starting antibiotics.
- You do not have severe complications (like severe breathing, kidney, or heart problems) or other serious bacterial infections.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests ways to prevent early and late complications of leptospirosis, a bacterial infection. It aims to offer treatments that may reduce the risk of serious problems like kidney failure or breathing difficulties.
This study looks at how your blood cells react to the bacteria that cause leptospirosis, and tests a new treatment that may help your immune system fight the infection better.
This trial tests a structured set of hospital treatments (“care bundle”) for adults with suspected leptospirosis, a serious infection often linked to flood water exposure. It may help by improving how quickly and consistently key care steps are delivered in the hospital.
This study looks at how your body responds to leptospirosis, a bacterial infection spread by animals, to improve diagnosis and treatment. It compares people with leptospirosis, those with other infections, and healthy individuals to find better ways to detect the disease early.
This study tests whether taking an antibiotic, doxycycline, can help prevent leptospirosis, a bacterial infection you can get from water or soil that may be contaminated by animal urine. If you've been exposed to risky environments, this trial aims to see if the medicine can stop you from getting sick.
This study records information from people who have invasive (spreading) leptospirosis, a bacterial infection. The goal is to better understand how the disease presents and spreads, which can help improve future care.
Hear when a new Mild Leptospirosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.